Table 1 |
|||
|
Summary of cases, injection sites and hemisphere, tracers, and analyses |
|||
|
Case |
Injection site(s), (hemisphere) |
Tracer |
Label type* #, areas analysed |
|
|
|||
|
AV |
O12, IML (left) |
fr, fb |
hypothalamus* (fr); # (fb), amygdala# (fr); |
|
AW |
LA (right) |
fb |
prefrontal cortex#; amygdala# |
|
AX |
LA (left) |
BDA |
prefrontal cortex#,*; amygdala#,*; brainstem, IML* |
|
AY |
32 (right) |
BDA |
LA*; synapses from area 32 in LA (EM) |
|
BG |
32 (right) |
BDA |
PA*; synapses from area 32 in PA (EM) |
|
|
|||
|
*Anterograde label; #retrograde label |
|||
|
Barbas et al. BMC Neuroscience 2003 4:25 doi:10.1186/1471-2202-4-25 |
|||
